Skip to content
Screener

Baxter International BAX Healthcare Systems & Technologies — Currency translation and other

Other segment segments

Medical Products & Therapies
$80M+243%
Pharmaceuticals
$37M+261%

Similar metrics at other companies

IR
IRIndustrial Technologies and Services — Foreign currency translation and other
-$25.8M-156%
IR
IRPrecision and Science Technologies — Foreign currency translation and other
-$9.9M-131%
Matthews International logo
MATWIndustrial Technologies — Translation and other adjustments
-$397K-192%
GTL
GTLSHeat Transfer Systems — Foreign currency translation adjustments and other
$400K-73.3%
Air Products and Chemicals logo
APDCorporate And Other — Currency translation
$100K-66.7%
Raytheon Technologies logo
RTXRaytheon — Foreign Currency Translation and Other
-$1M-200%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments.

The source filing: Baxter International’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 4:46 PM EST
Fiscal year
FY2025
Accession
0001628280-26-007733
(in millions)Medical Products & TherapiesHealthcare Systems & TechnologiesPharmaceuticalsTotal
December 31, 2023$1,241$3,989$563$5,793
Impairments(425)(425)
Currency translation and other(56)(14)(23)(93)
December 31, 2024$1,185$3,550$540$5,275
Impairments(485)(485)
Currency translation and other802237139
December 31, 2025$1,265$3,087$577$4,929

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Baxter International's healthcare systems & technologies — currency translation and other?
Baxter International (BAX) reported healthcare systems & technologies — currency translation and other of $5.5M in Q4 2025.
How has Baxter International's healthcare systems & technologies — currency translation and other changed year-over-year?
Baxter International's healthcare systems & technologies — currency translation and other increased by 257.1% year-over-year, from -$3.5M to $5.5M.
What is the long-term trend for Baxter International's healthcare systems & technologies — currency translation and other?
Over 3 years (2022 to 2025), Baxter International's healthcare systems & technologies — currency translation and other has grown at a -14.3% compound annual growth rate (CAGR), from -$35M to $22M.
What does healthcare systems & technologies — currency translation and other mean?
This metric represents the net impact of foreign exchange rate fluctuations and miscellaneous non-operating adjustments on the segment's reported financial results. It captures the volatility inherent in translating international revenue and expenses back into the reporting currency. Monitoring this helps investors isolate organic operational performance from macroeconomic currency shifts.

Ask your AI about Baxter International's healthcare systems & technologies — currency translation and other.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude